Eli Lilly and Company Invests $100 Million in China Animal Healthcare Ltd.

by Richard Daverman, PhD

April 10, 2013 -- Eli Lilly’s animal health division, Elanco, will make a $100 million investment into China Animal Healthcare Ltd. The capital, which will give Elanco a 20% stake in China Animal Health, will be used, in part, to de-list China Animal Health from the Singapore Stock Exchange. China Animal Health IPO’d in Singapore in 2007, and then instituted a secondary listing in Hong Kong in 2010. Elanco said the two companies have set up a framework for future collaborations. More details....

Stock Symbols: (NYSE: LLY) (SG: CAL; HK: 940)